Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
1.530
+0.030 (2.00%)
At close: May 14, 2025, 4:00 PM
1.620
+0.090 (5.88%)
After-hours: May 14, 2025, 7:44 PM EDT
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $8.40 million as of May 14, 2025. Its market cap has decreased by -70.24% in one year.
Market Cap
8.40M
Enterprise Value
-10.76M
1-Year Change
-70.24%
Ranking
Category
Stock Price
$1.53
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $8.40M, a decrease of -55.62%. That is a compound annual growth rate of -23.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 8.24M | -53.93% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 669.76B |
| Johnson & Johnson | 357.16B |
| AbbVie | 332.08B |
| Novo Nordisk | 291.59B |
| UnitedHealth Group | 282.47B |
| Abbott Laboratories | 224.53B |
| Novartis AG | 209.81B |
| AstraZeneca | 209.59B |